Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Forma Therapeutics (Cambridge, MA) a development-stage screening and discovery company focused on cancer therapies, closed a $25.5M Series B financing. Participants include Lilly Ventures, Novartis Option Fund and Bio*One Capital. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Therasis (New York, NY) a development-stage computational systems biology cancer HTS drug discovery platform, closed a $12M Series A financing. Participants include Tilocor Life Science. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Ligon Discovery (Cambridge, MA) a development-stage HTS drug-discovery platform employing Small Molecule Microarray technology, closed a $1M seed financing. Participants include incTank Ventures. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

  

to top of page...